427 related articles for article (PubMed ID: 26164096)
21. [Risk factors for perioperative complications in renal surgery for Wilms' tumor].
Seseke F; Rebmann S; Zöller G; Lakomek M; Ringert RH
Aktuelle Urol; 2007 Jan; 38(1):46-51. PubMed ID: 17290329
[TBL] [Abstract][Full Text] [Related]
22. Treatment of childhood Wilms' tumor without radiotherapy in Nicaragua.
Baez F; Fossati Bellani F; Ocampo E; Conter V; Flores A; Gutierrez T; Malta A; Mendez G; Pacheco C; Palacios R; Sala A; Galimberti S; Cavalli F; Masera G
Ann Oncol; 2002 Jun; 13(6):944-8. PubMed ID: 12123340
[TBL] [Abstract][Full Text] [Related]
23. Outcome of children with cystic partially differentiated nephroblastoma treated with or without chemotherapy.
Blakely ML; Shamberger RC; Norkool P; Beckwith JB; Green DM; Ritchey ML;
J Pediatr Surg; 2003 Jun; 38(6):897-900. PubMed ID: 12778388
[TBL] [Abstract][Full Text] [Related]
24. Wilms tumour in Malawi: surgical staging to stratify postoperative chemotherapy?
Borgstein E; Kamiza S; Vujanic G; Pidini D; Bailey S; Tomoka T; Banda K; Kaspers G; Molyneux E; Israels T
Pediatr Blood Cancer; 2014 Dec; 61(12):2180-4. PubMed ID: 25213396
[TBL] [Abstract][Full Text] [Related]
25. Treatment of Wilms' tumour. Current recommendations.
Mehta MP; Bastin KT; Wiersma SR
Drugs; 1991 Nov; 42(5):766-80. PubMed ID: 1723373
[TBL] [Abstract][Full Text] [Related]
26. [Preoperative chemotherapy of nephroblastoma. Preliminary results of the SIOP-9/GPO therapy study].
Ludwig R; Weirich A; Pötter R; Harms D; Bürger D; Michaelis J; Erttmann R; Weinel P; Haas RJ; Ritter J
Klin Padiatr; 1992; 204(4):204-13. PubMed ID: 1325574
[TBL] [Abstract][Full Text] [Related]
27. Outcomes of non-anaplastic stage III and 'inoperable' Wilms tumour treated in the UKW3 trial.
Irtan S; Messahel B; Moroz V; Taylor RE; Grundy R; Kelsey A; Vujanic G; Pritchard-Jones K;
Radiother Oncol; 2019 Feb; 131():1-7. PubMed ID: 30773174
[TBL] [Abstract][Full Text] [Related]
28. Addition of dose-intensified doxorubicin to standard chemotherapy for rhabdomyosarcoma (EpSSG RMS 2005): a multicentre, open-label, randomised controlled, phase 3 trial.
Bisogno G; Jenney M; Bergeron C; Gallego Melcón S; Ferrari A; Oberlin O; Carli M; Stevens M; Kelsey A; De Paoli A; Gaze MN; Martelli H; Devalck C; Merks JH; Ben-Arush M; Glosli H; Chisholm J; Orbach D; Minard-Colin V; De Salvo GL;
Lancet Oncol; 2018 Aug; 19(8):1061-1071. PubMed ID: 29941280
[TBL] [Abstract][Full Text] [Related]
29. Preoperative chemotherapy in the management of intracaval extension of Wilms' tumor.
Crombleholme TM; Jacir NN; Rosenfield CG; Lew S; Harris BH
J Pediatr Surg; 1994 Feb; 29(2):229-31. PubMed ID: 8176597
[TBL] [Abstract][Full Text] [Related]
30. Effect of duration of treatment on treatment outcome and cost of treatment for Wilms' tumor: a report from the National Wilms' Tumor Study Group.
Green DM; Breslow NE; Beckwith JB; Finklestein JZ; Grundy P; Thomas PR; Kim T; Shochat S; Haase G; Ritchey M; Kelalis P; D'Angio GJ
J Clin Oncol; 1998 Dec; 16(12):3744-51. PubMed ID: 9850017
[TBL] [Abstract][Full Text] [Related]
31. Treatment of anaplastic histology Wilms' tumor: results from the fifth National Wilms' Tumor Study.
Dome JS; Cotton CA; Perlman EJ; Breslow NE; Kalapurakal JA; Ritchey ML; Grundy PE; Malogolowkin M; Beckwith JB; Shamberger RC; Haase GM; Coppes MJ; Coccia P; Kletzel M; Weetman RM; Donaldson M; Macklis RM; Green DM
J Clin Oncol; 2006 May; 24(15):2352-8. PubMed ID: 16710034
[TBL] [Abstract][Full Text] [Related]
32. Doxorubicin for favorable histology, Stage II-III Wilms tumor: results from the National Wilms Tumor Studies.
Breslow NE; Ou SS; Beckwith JB; Haase GM; Kalapurakal JA; Ritchey ML; Shamberger RC; Thomas PR; D'Angio GJ; Green DM
Cancer; 2004 Sep; 101(5):1072-80. PubMed ID: 15329918
[TBL] [Abstract][Full Text] [Related]
33. Four versus six cycles of CHOP chemotherapy in combination with six applications of rituximab in patients with aggressive B-cell lymphoma with favourable prognosis (FLYER): a randomised, phase 3, non-inferiority trial.
Poeschel V; Held G; Ziepert M; Witzens-Harig M; Holte H; Thurner L; Borchmann P; Viardot A; Soekler M; Keller U; Schmidt C; Truemper L; Mahlberg R; Marks R; Hoeffkes HG; Metzner B; Dierlamm J; Frickhofen N; Haenel M; Neubauer A; Kneba M; Merli F; Tucci A; de Nully Brown P; Federico M; Lengfelder E; di Rocco A; Trappe R; Rosenwald A; Berdel C; Maisenhoelder M; Shpilberg O; Amam J; Christofyllakis K; Hartmann F; Murawski N; Stilgenbauer S; Nickelsen M; Wulf G; Glass B; Schmitz N; Altmann B; Loeffler M; Pfreundschuh M; ;
Lancet; 2019 Dec; 394(10216):2271-2281. PubMed ID: 31868632
[TBL] [Abstract][Full Text] [Related]
34. The efficacy and toxicity of SIOP preoperative chemotherapy in Malawian children with a Wilms tumour.
Israels T; Chagaluka G; Pidini D; Caron H; de Kraker J; Kamiza S; Borgstein E; Molyneux L
Pediatr Blood Cancer; 2012 Oct; 59(4):636-41. PubMed ID: 22271712
[TBL] [Abstract][Full Text] [Related]
35. Surgical complications in the treatment of Wilms' tumor.
Stehr M; Deilmann K; Haas RJ; Dietz HG
Eur J Pediatr Surg; 2005 Dec; 15(6):414-9. PubMed ID: 16418959
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of boost irradiation in patients with intermediate-risk stage III Wilms tumour with positive lymph nodes only: Results from the SIOP-WT-2001 Registry.
Dávila Fajardo R; Oldenburger E; Rübe C; López-Yurda M; Pritchard-Jones K; Bergeron C; Graf N; van Grotel M; van Tinteren H; Saunders D; van den Heuvel-Eibrink MM; Janssens GO; Oldenburger F
Pediatr Blood Cancer; 2018 Aug; 65(8):e27085. PubMed ID: 29693799
[TBL] [Abstract][Full Text] [Related]
37. Risk factors for local recurrence in Wilms tumour and the potential influence of biopsy - the United Kingdom experience.
Irtan S; Jitlal M; Bate J; Powis M; Vujanic G; Kelsey A; Walker J; Mitchell C; Machin D; Pritchard-Jones K;
Eur J Cancer; 2015 Jan; 51(2):225-32. PubMed ID: 25465191
[TBL] [Abstract][Full Text] [Related]
38. Wilms' tumor in the neonate: a report from the National Wilms' Tumor Study.
Hrabovsky EE; Othersen HB; deLorimier A; Kelalis P; Beckwith JB; Takashima J
J Pediatr Surg; 1986 May; 21(5):385-7. PubMed ID: 3012057
[TBL] [Abstract][Full Text] [Related]
39. Adult Wilms' tumor.
Sharma MS; Ahmed MZ
Saudi J Kidney Dis Transpl; 2009 Sep; 20(5):835-7. PubMed ID: 19736484
[TBL] [Abstract][Full Text] [Related]
40. Outcome of localised blastemal-type Wilms tumour patients treated according to intensified treatment in the SIOP WT 2001 protocol, a report of the SIOP Renal Tumour Study Group (SIOP-RTSG).
van den Heuvel-Eibrink MM; van Tinteren H; Bergeron C; Coulomb-L'Hermine A; de Camargo B; Leuschner I; Sandstedt B; Acha T; Godzinski J; Oldenburger F; Gooskens SL; de Kraker J; Vujanic GM; Pritchard-Jones K; Graf N
Eur J Cancer; 2015 Mar; 51(4):498-506. PubMed ID: 25592561
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
